Emmes Group, a specialty tech and AI-enabled global contract research organization (CRO), has appointed Germaine Gross as Chief Commercial Officer of Emmes Biopharma. With more than 30 years in life sciences and 15 years leading CRO Business Development efforts, Gross will spearhead the next phase of growth in Emmes Biopharma’s business portfolio. Reporting directly to Emmes Group Chief Executive Officer Sastry Chilukuri and serving on the company’s Executive Management Committee,...